Nellcor Puritan Bennett--Delivering Patient-Centric Care
Executive Summary
Nellcor faces a challenge-how to respond to the new integrated delivery system that was beginning to ask for products across a spectrum of care. Nellcor's acquisition of respiratory products company Puritan Bennett represented the company's boldest effort to date to fulfill the vision of integrated delivery of care. Now the major challenge Nellcor Puritan Bennett faces is: are these new customers real and are they truly ready for this new approach to care?
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.